Perrigo (PRGO) Consolidated Net Income (2012 - 2026)
Perrigo (PRGO) reported Consolidated Net Income of -$8.7 million for Q1 2026, down 33.85% year-over-year from -$13.2 million in Q1 2025, and down 148.57% quarter-over-quarter from -$3.5 million in Q4 2025.
Perrigo (PRGO) Consolidated Net Income (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of Consolidated Net Income data on file, last reported at -$8.7 million in Q1 2026.
- Consolidated Net Income for Q1 2026 came in at -$8.7 million, down 33.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$25.3 million (down 62.18% YoY), and the FY2025 annual result was -$23.1 million, down 108.11% from the prior year.
- Consolidated Net Income retreated to -$8.7 million in Q1 2026 per PRGO's latest filing, from -$3.5 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at $2.7 million in Q4 2022 and troughed at -$11.0 million in Q4 2022.
- A 5-year average of -$3.6 million and a median of -$3.0 million in 2024 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2022 and 2024: Consolidated Net Income jumped 154.0% in 2022, then plunged 440.0% in 2024.
- A 5-year view of Consolidated Net Income shows it stood at -$11.0 million in 2022, then surged by 58.18% to -$4.6 million in 2023, then surged by 34.78% to -$3.0 million in 2024, then declined by 16.67% to -$3.5 million in 2025, then plunged by 148.57% to -$8.7 million in 2026.
- Business Quant data shows PRGO's Consolidated Net Income at -$8.7 million in Q1 2026, -$3.5 million in Q4 2025, and -$5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -114,733.81 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Perrigo | 1.61 Bn | 1.25 Bn | 325.50 Mn | -8.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -8.70 Mn |
| Dec 31, 2025 | -3.50 Mn |
| Sep 27, 2025 | -5.20 Mn |
| Jun 28, 2025 | -7.90 Mn |
| Mar 29, 2025 | -6.50 Mn |
| Dec 31, 2024 | -3.00 Mn |
| Sep 28, 2024 | -3.40 Mn |
| Jun 29, 2024 | -2.70 Mn |
| Mar 30, 2024 | -2.10 Mn |
| Dec 31, 2023 | -4.60 Mn |
| Sep 30, 2023 | -1.20 Mn |
| Jul 1, 2023 | -500,000.00 |
| Apr 1, 2023 | -1.90 Mn |
| Dec 31, 2022 | -11.00 Mn |
| Oct 1, 2022 | 2.70 Mn |
| Jul 2, 2022 | -200,000.00 |
| Apr 2, 2022 | -1.10 Mn |
| Dec 31, 2021 | -22.50 Mn |
| Oct 2, 2021 | -5.00 Mn |
| Jul 3, 2021 | 54.20 Mn |